Search by Drug Name or NDC

    NDC 00480-8725-01 Levothyroxine sodium 300 ug/1 Details

    Levothyroxine sodium 300 ug/1

    Levothyroxine sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals, Inc.. The primary component is LEVOTHYROXINE SODIUM.

    Product Information

    NDC 00480-8725
    Product ID 0480-8725_b7b0021f-f2a3-47a2-9860-0787d9965b77
    Associated GPIs
    GCN Sequence Number 006657
    GCN Sequence Number Description levothyroxine sodium TABLET 300 MCG ORAL
    HIC3 P3A
    HIC3 Description THYROID HORMONES
    GCN 26329
    HICL Sequence Number 002849
    HICL Sequence Number Description LEVOTHYROXINE SODIUM
    Brand/Generic Generic
    Proprietary Name Levothyroxine sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levothyroxine sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units ug/1
    Substance Name LEVOTHYROXINE SODIUM
    Labeler Name Teva Pharmaceuticals, Inc.
    Pharmaceutical Class Thyroxine [CS], l-Thyroxine [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207588
    Listing Certified Through 2024-12-31

    Package

    NDC 00480-8725-01 (00480872501)

    NDC Package Code 0480-8725-01
    Billing NDC 00480872501
    Package 100 TABLET in 1 BOTTLE (0480-8725-01)
    Marketing Start Date 2022-09-21
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 60cadfd7-82b5-4207-97e1-1dd0655efb27 Details

    Revised: 9/2022